Journal of Applied Physiology, Vol 64, Issue 2 556-561, Copyright © 1988 by American Physiological Society

ARTICLES

Plasma adenosine and hypoxemia in patients with sleep apnea

L. J. Findley, M. Boykin, T. Fallon and L. Belardinelli
Department of Internal Medicine, University of Virginia, Charlottesville 22908.

Severe hypoxemia causes ATP depletion and increased adenosine production in many body tissues. Therefore we hypothesized that patients with sleep apnea and severe hypoxemia during sleep have higher adenosine production and higher plasma adenosine levels than patients without hypoxemia. Twelve patients with sleep apnea and six normal volunteers had plasma adenosine levels measured by high-performance liquid chromatography. Each patient with sleep apnea had a polysomnograph sleep study with oxyhemoglobin saturation continuously recorded. Five of 12 patients with sleep apnea had both sleep apnea and severe hypoxemia during sleep. These patients with severe nocturnal hypoxemia had significantly higher plasma adenosine levels (means +/- SD 9.7 +/- 5.5 X 10(-8) M) than either a group of six normal volunteers (3.5 +/- 0.7 X 10(-8) M) or a group of seven patients with sleep apnea without hypoxemia at night (3.1 +/- 1.5 X 10(-8) M) (P less than 0.01). In addition plasma adenosine levels were significantly correlated with two indexes of nocturnal hypoxemia (desaturation index rs = 0.79, and median oxyhemoglobin saturation during sleep rs = -0.75, P less than 0.01). Plasma adenosine markedly fell to a normal level in the only two patients with sleep apnea who had successful treatment of their multiple apneas and accompanying severe hypoxemia during sleep.

This article has been cited by other articles:

				B. Buyse, J. Hedner, and the participants of working group 2 Sleep apnoea, hypertension and vascular disease: where are we now? Eur. Respir. Rev., December 1, 2007; 16(106): 169 - 182. [Abstract] [Full Text] [PDF]

				S. L. Verhulst, K. Van Hoeck, N. Schrauwen, D. Haentjens, R. Rooman, L. Van Gaal, W. A. De Backer, and K. N. Desager Sleep-Disordered Breathing and Uric Acid in Overweight and Obese Children and Adolescents Chest, July 1, 2007; 132(1): 76 - 80. [Abstract] [Full Text] [PDF]

				H. Saito, M. Nishimura, E. Shibuya, H. Makita, I. Tsujino, K. Miyamoto, and Y. Kawakami Tissue Hypoxia in Sleep Apnea Syndrome Assessed by Uric Acid and Adenosine Chest, November 1, 2002; 122(5): 1686 - 1694. [Abstract] [Full Text] [PDF]

				W. Jordan, J. Hagedohm, J. Wiltfang, G. Laier-Groeneveld, H. Tumani, A. Rodenbeck, E. Ruther, and G. Hajak Biochemical markers of cerebrovascular injury in sleep apnoea syndrome Eur. Respir. J., July 1, 2002; 20(1): 158 - 164. [Abstract] [Full Text] [PDF]

				L. Lavie, A. Perelman, and P. Lavie Plasma Homocysteine Levels in Obstructive Sleep Apnea : Association With Cardiovascular Morbidity Chest, September 1, 2001; 120(3): 900 - 908. [Abstract] [Full Text] [PDF]

				F. Han, E. Chen, H. Wei, Q. He, D. Ding, and K. P. Strohl Treatment Effects on Carbon Dioxide Retention in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome Chest, June 1, 2001; 119(6): 1814 - 1819. [Abstract] [Full Text] [PDF]

				H. SAITO, M. NISHIMURA, H. SHINANO, H. MAKITA, I. TSUJINO, E. SHIBUYA, F. SATO, K. MIYAMOTO, and Y. KAWAKAMI Plasma Concentration of Adenosine during Normoxia and Moderate Hypoxia in Humans Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 1014 - 1018. [Abstract] [Full Text]

				D. W. HUDGEL and S. THANAKITCHARU Pharmacologic Treatment of Sleep-disordered Breathing Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 691 - 699. [Abstract] [Full Text] [PDF]